Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Neurotoxicology. 2009 Apr 8;30(4):613–621. doi: 10.1016/j.neuro.2009.03.009

Table 1.

Voltages of half inactivation (V0.5) and slopes (k) of fast and slow inactivation curves for BgNav1-1a BgNav1-1aF1817A, and BgNav1-1aY1824A sodium channels treated with indoxacarb or DCJW at depolarized holding potentials


Control Indoxacarb DCJW Metaflumizone

V0.5 (mV) k V0.5 (mV) k V0.5 (mV) k V0.5 (mV) k

Fast Inact
BgNav1-1a -48.9 ± 0.8 5.9 ± 0.4 -50.8 ± 1.5 6.4 ± 0.7 -48.3 ± 0.9 5.2 ± 0.1 -45.2 ± 1.3 4.0 ± 0.4
BgNav1-1aF1817A -48.4 ± 1.6 4.8 ± 0.2 -52.2 ± 1.2 6.0 ± 0.3 -49.9 ± 1.7 9.1 ± 2.0b -46.3 ± 1.0 4.8 ± 0.2
BgNav1-1aY1824A -45.2 ± 1.6 5.5 ± 0.4 -41.1 ± 1.2 4.9 ± 0.2 -40.4 ± 1.0 5.0 ± 0.2 -40.0 ± 0.9 5.0 ± 0.1
Slow Inact
BgNav1-1a -54.6 ± 0.9 4.2 ± 0.2 -64.6 ± 1.6 6.78 ± 0.4 -71.8 ± 3.8b 13.1 ± 1.0b -51.1 ± 1.4 8.2 ± 0.2b
BgNav1-1aF1817A -66.4 ± 0.4a 3.8 ± 0.2 -71.9 ± 0.9b 5.2 ± 0.3 -99.5 ± 1.0b 10.1 ± 0.1b -81.0 ± 1.6b 13.5 ± 0.6b
BgNav1-1aY1824A -61.4 ± 2.0a 7.8 ± 0.8a -57.0 ± 4.2 7.1 ± 1.4 -57.8 ± 4.1 8.9 ± 2.1 -54.8 ± 0.9 6.9 ± 0.6
a

significantly different from wild-type (BgNav1-1a, p < 0.05, n ≥ 3)

b

significantly different from control (p < 0.05, n ≥ 3)